Skip to main content
Premium Trial:

Request an Annual Quote

Discovery Manager 3.0, Progenesis, SRS 6.1, GeneX Gene Expression Database

Premium

Genomica of Boulder, Colo., has released Discovery Manager 3.0.

Enhancements to the latest version of the genetic analysis product suite include the ability to integrate SNP data from Orchid BioSciences’ SNPstream 25K genotyping platform.

Nonlinear Dynamics of Newcastle upon Tyne, UK, has launched Progenesis, an automated image analysis system for 2D gel electrophoresis.

Progenesis is designed for spot detection, measurement, and matching in high-throughput proteomics requirements.

The product’s official launch will take place at Drug Discovery Technology 2001, Stuttgart, April 25, and at Proteomics 2001, Philadelphia, May 16.

SRS 6.1 is now available from Lion Bioscience of Heidelberg, Germany.

The latest release of the system can integrate flat-file, XML, and relational databases into a single system. It also offers virtual libraries to give users flexibility in presenting data to their customers, support for additional indexing technologies, and improved application launching capabilities.

SRS 6.1 was introduced at the SRS User Meeting last week in Cambridge, UK.

A public release of the GeneX Gene Expression Database system is now available from the National Center for Genome Resources at http://genex.ncgr.org.

GeneX is an open source project and is licensed under the GNU LGPL. It provides a basic working system that includes installation scripts, example data, a Genex.pm Perl wrapper API to the database, utilities to manipulate the XML transport format, and analytical tools that can be used with data from the database or with data uploaded directly.

GeneX supports multiple kinds of array data and can share data via XML.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.